ATI vs PRLB vs SOLS Stock Comparison

Ati, Proto Labs and Solstice Advanced Materials Prices as of Oct 23, 2026 Peers: Industry group
1 more company in this comparison (EMN) Create a free account to keep reading and compare up to 10 companies.
ATI Ati Inc
$156.88 -14.7% 1M +75.2% 1Y
Market cap
$22.42B
P/E
47.1x
Revenue (TTM)
$4.72B
Div. yield
–
Specialty Chemicals Basic Materials
6 wins
PRLB Proto Labs Inc
$85.54 -4.2% 1M +54.8% 1Y
Market cap
$2.07B
P/E
67.8x
Revenue (TTM)
$560.54M
Div. yield
–
3D Printing Industrials
2 wins

Head to Head

11 decided of 12

Ati leads on 6 of the 12 questions below (Ati 6, Solstice Advanced Materials 3, Proto Labs 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionATIPRLBSOLSLeader
Larger companyMarket capitalisation $22.42B $2.07B $9.59B ATI
Cheaper on earningsLower P/E, profitable companies only 47.1x 67.8x 45.7x SOLS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 32.9x 37.4x 22.0x SOLS
Faster revenue growthRevenue growth, trailing twelve months +4.6% +10.2% +9.2% PRLB
More profitableNet margin, trailing twelve months 10.1% 5.4% 5.1% ATI
Better return on capitalReturn on invested capital 14.9% — 9.8% ATI
Less leveragedLower net debt / EBITDA 1.6x — 1.3x SOLS
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +75.2% +54.8% +29.2% ATI
Better 5-year returnAnnualised price return, 5 years +58.0%/yr +3.7%/yr — ATI
Less volatileAnnualised volatility, 1 year 41.7% 46.8% 54.8% ATI
Higher overall scoreMean of the five percentile scores vs peers 58/100 59/100 38/100 PRLB

Percentile Scorecard

ATIPRLBSOLS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisATIPRLBSOLS
Valuation 14 #81 of 94 34 #135 of 203 38 #59 of 94
Growth 88 #12 of 92 83 #32 of 188 21 #73 of 92
Profitability 91 #9 of 89 52 #91 of 187 78 #20 of 89
Financial Health 49 #50 of 97 96 #11 of 222 42 #57 of 97
Shareholder Returns 48 #37 of 70 32 #104 of 153 13 #61 of 70
Overall 58 59 38
  • ATI ranked among 99 companies in Chemicals
  • PRLB ranked among 222 companies in Machinery
  • SOLS ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodATIPRLBSOLSSPY
1 month -14.7%-4.2%+2.5% -1.0%
3 months -20.7%+9.2%-1.9% +2.9%
6 months +1.7%+32.4%-26.9% +6.4%
Year to date +36.7%+69.1%+22.3% +11.4%
1 year +75.2%+54.8%+29.2% +13.1%
3 years +329.0%+251.1%— +79.4%
3 years, per year +62.5%+52.0%— +21.5%
5 years +882.3%+19.7%— +67.7%
5 years, per year +58.0%+3.7%— +10.9%
10 years +782.8%+59.8%— +255.2%
10 years, per year +24.3%+4.8%— +13.5%

Risk

MeasureATIPRLBSOLSSPY
Volatility, 1Y 41.7%46.8%54.8% 12.7%
Downside volatility, 1Y 40.3%38.7%54.0% 12.7%
Beta vs S&P 500, 1Y 1.632.031.53 1.00
Return / volatility, 1Y 1.801.170.53 1.03
Max drawdown, 5Y -38.0%-71.4%-37.5% -25.4%
From 52-week high -32.3%-13.3%-32.9% -2.5%
52-week high $231.79$98.64$88.60 $779.14
52-week low $89.25$46.81$41.43 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleATIPRLBSOLS
P/E now vs peer median 44.9xmedian 21.5x 67.3xmedian 25.9x 44.9xmedian 21.5x
P/S now vs peer median 4.5xmedian 1.4x 3.7xmedian 1.9x 2.3xmedian 1.4x
EV/EBITDA now vs peer median 25.5xmedian 12.4x 27.4xmedian 13.7x 11.7xmedian 12.4x
P/FCF now vs peer median 40.6xmedian 15.5x 36.1xmedian 21.1x 48.4xmedian 15.5x
P/B now vs peer median 10.7xmedian 1.6x 3.0xmedian 2.3x 5.9xmedian 1.6x
PEG now vs peer median 5.07median 1.70 2.10median 1.19 —median 1.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsATIPRLBSOLS
Revenue $4.72B $560.54M $4.10B
Gross profit $1.10B $254.60M $1.25B
Operating income $716.80M $36.81M $692.00M
Net income $488.90M $30.48M $258.00M
Free cash flow $526.30M $56.66M $195.00M
R&D – $42.36M $106.00M
EPS (diluted) $3.44 $1.25 $1.32
Cash & equivalents $783.00M $127.92M $750.00M
Total debt $2.19B – $4.25B
Shares (diluted) 138.30M 24.42M 159.40M
Enterprise value $20.44B $1.54B $7.25B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricATIPRLBSOLS
P/E 44.9x 67.3x 44.9x
P/FCF 40.6x 36.1x 48.4x
P/Operating cash flow 26.5x 26.1x 15.6x
P/S 4.5x 3.7x 2.3x
P/B 10.7x 3.0x 5.9x
P/Tangible book 10.7x 3.0x 6.1x
EV/EBITDA 25.5x 27.4x 11.7x
EV/EBIT 31.8x 51.7x 15.4x
EV/Revenue 4.8x 3.4x 2.6x
EV/FCF 43.3x 33.6x 54.7x
EV/Operating cash flow 28.3x 24.2x 17.6x
PEG (3Y EPS CAGR) 5.07 2.10 –

Growth

14 metrics
MetricATIPRLBSOLS
Revenue growth (1Y) 4.6% 10.2% 9.2%
Revenue CAGR (3Y) 4.5% 4.9% –
Gross profit growth (1Y) 15.7% 13.3% -4.9%
Gross profit CAGR (3Y) 12.6% 6.8% –
Operating income growth (1Y) 8.8% 121.9% -17.4%
Operating income CAGR (3Y) 16.4% 33.2% –
Net income growth (1Y) 12.9% 105.8% -50.9%
Net income CAGR (3Y) 5.8% 31.6% –
EPS growth (1Y) 17.9% 103.1% -59.5%
EPS CAGR (3Y) 8.9% 32.0% –
Operating cash flow growth (1Y) 69.9% 10.6% –
Operating cash flow CAGR (3Y) – 7.7% –
Free cash flow growth (1Y) 123.6% -14.0% –
Free cash flow CAGR (3Y) – 11.9% –

Profitability

14 metrics
MetricATIPRLBSOLS
Gross margin 23.4% 45.4% 30.6%
EBITDA margin 18.9% 12.4% 22.3%
Operating margin 15.2% 6.6% 16.9%
Pretax margin 12.7% 7.6% 13.9%
Net margin 10.1% 5.4% 5.1%
FCF margin 11.2% 10.1% 4.8%
Operating cash flow margin 17.1% 14.0% 14.8%
Return on equity 25.2% 4.4% 18.6%
Return on assets 8.9% 3.9% 4.9%
Return on invested capital 14.9% – 9.8%
Return on capital employed 17.6% 5.2% 17.0%
Asset turnover 0.9x 0.7x 0.7x
Cash conversion (OCF / net income) 1.6x 2.6x 2.3x
Stock comp / revenue 0.6% 2.6% 0.6%

Financial Health

11 metrics
MetricATIPRLBSOLS
Debt / assets 38.2% – 33.3%
Debt / equity 1.1x – 1.2x
Net debt / EBITDA 1.6x – 1.3x
Debt / FCF 4.2x – 10.1x
Liabilities / assets 65.2% 12.6% 73.2%
Equity / assets 34.8% 87.4% 26.8%
Interest coverage – – 9.0x
Current ratio 2.3x 3.6x 1.5x
Quick ratio 1.1x 3.2x 0.8x
Cash ratio 0.6x 2.0x 0.4x
Altman Z-score 5.23 13.94 2.60

Shareholder Returns

7 metrics
MetricATIPRLBSOLS
Dividend yield – – 0.4%
Net buyback yield 1.3% 0.6% –
Shareholder yield 1.3% 0.6% 0.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusATIPRLBSOLS
Forward P/E 32.9xFY2026 37.4xFY2026 22.0xFY2026
EPS, next fiscal year $4.77FY2026 $2.29FY2026 $2.70FY2026
EPS growth, next FY +47.2%FY2026 +38.0%FY2026 +81.2%FY2026
EPS growth, the year after +23.5% +9.6% +33.3%
Revenue, next fiscal year $5.24BFY2026 $612.12MFY2026 $4.44BFY2026
Revenue growth, next FY +14.2%FY2026 +14.8%FY2026 +14.2%FY2026
Revenue growth, the year after +13.1% +4.8% -4.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersATIPRLBSOLS
Held by institutions 93.5% 93.7% –
Institutions holding 785 276 –
Change in shares held, QoQ +0.9% +1.7% –
Institutions buying 478 145 –
Institutions selling 217 89 –
Buyers to sellers 2.20 1.63 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ATIPRLBSOLS
ATI 1.00 0.44 0.40
PRLB 0.44 1.00 0.40
SOLS 0.40 0.40 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ATI, PRLB and SOLS?

Ati (ATI) is the largest by market capitalisation: Ati (ATI) $22.42B, Proto Labs (PRLB) $2.07B, Solstice Advanced Materials (SOLS) $9.59B.

Which stock is cheaper, ATI, PRLB and SOLS?

Solstice Advanced Materials (SOLS) trades on the lowest price-to-earnings ratio (Ati (ATI) 47.1x, Proto Labs (PRLB) 67.8x, Solstice Advanced Materials (SOLS) 45.7x). On next year's consensus earnings, Solstice Advanced Materials (SOLS) is cheapest (Ati (ATI) 32.9x, Proto Labs (PRLB) 37.4x, Solstice Advanced Materials (SOLS) 22.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Proto Labs (PRLB) grew revenue fastest over the trailing twelve months: Ati (ATI) +4.6%, Proto Labs (PRLB) +10.2%, Solstice Advanced Materials (SOLS) +9.2%.

Which company is more profitable?

Ati (ATI) has the highest net margin (Ati (ATI) 10.1%, Proto Labs (PRLB) 5.4%, Solstice Advanced Materials (SOLS) 5.1%). On return on invested capital, Ati (ATI) leads (Ati (ATI) 14.9%, Solstice Advanced Materials (SOLS) 9.8%).

Which stock has performed better?

Over the past year Ati (ATI) returned the most: Ati (ATI) +75.2%, Proto Labs (PRLB) +54.8%, Solstice Advanced Materials (SOLS) +29.2%. Over five years, Ati (ATI) compounded fastest (Ati (ATI) +58.0%/yr, Proto Labs (PRLB) +3.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ati (ATI) has been the steadiest (Ati (ATI) 41.7%, Proto Labs (PRLB) 46.8%, Solstice Advanced Materials (SOLS) 54.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ATI, PRLB and SOLS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Ati (ATI) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.